Literature DB >> 17881667

Changes in serum levels of glucosamine and sulphate after ingestion of glucosamine sulphate with and without simultaneous ingestion of glucose.

Beth A Biggee, Christina M Blinn, Melynn Nuite, Timothy E McAlindon, Jeremiah E Silbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17881667      PMCID： PMC1994308          DOI： 10.1136/ard.2007.073205

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Chondroitin sulfate and other sulfate containing chondroprotective agents may exhibit their effects by overcoming a deficiency of sulfur amino acids.

Authors:  F Cordoba; M E Nimni
Journal:  Osteoarthritis Cartilage       Date:  2003-03       Impact factor: 6.576

2.  Sulfate could mediate the therapeutic effect of glucosamine sulfate.

Authors:  L J Hoffer; L N Kaplan; M J Hamadeh; A C Grigoriu; M Baron
Journal:  Metabolism       Date:  2001-07       Impact factor: 8.694

3.  Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis.

Authors:  B A Biggee; C M Blinn; M Nuite; J E Silbert; T E McAlindon
Journal:  Ann Rheum Dis       Date:  2006-07-03       Impact factor: 19.103

4.  Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man.

Authors:  S Persiani; E Roda; L C Rovati; M Locatelli; G Giacovelli; A Roda
Journal:  Osteoarthritis Cartilage       Date:  2005-09-13       Impact factor: 6.576

5.  Sulphate and osteoarthritis: decrease of serum sulphate levels by an additional 3-h fast and a 3-h glucose tolerance test after an overnight fast.

Authors:  C M Blinn; B A Biggee; T E McAlindon; M Nuite; J E Silbert
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

6.  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee.

Authors:  R Hughes; A Carr
Journal:  Rheumatology (Oxford)       Date:  2002-03       Impact factor: 7.580

7.  Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness.

Authors:  B A Biggee; C M Blinn; T E McAlindon; M Nuite; J E Silbert
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

8.  Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis.

Authors:  Florent Richy; Olivier Bruyere; Olivier Ethgen; Michel Cucherat; Yves Henrotin; Jean-Yves Reginster
Journal:  Arch Intern Med       Date:  2003-07-14

9.  Effect of glucosamine supplementation on fasting and non-fasting plasma glucose and serum insulin concentrations in healthy individuals.

Authors:  Allison J Tannis; John Barban; Julie A Conquer
Journal:  Osteoarthritis Cartilage       Date:  2004-06       Impact factor: 6.576

10.  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Authors:  Daniel O Clegg; Domenic J Reda; Crystal L Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245
  10 in total
  2 in total

1.  Dietary glucosamine under question.

Authors:  Jeremiah E Silbert
Journal:  Glycobiology       Date:  2009-03-02       Impact factor: 4.313

2.  Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities.

Authors:  Yves Henrotin; Xavier Chevalier; Gabriel Herrero-Beaumont; Timothy McAlindon; Ali Mobasheri; Karel Pavelka; Christiane Schön; Harrie Weinans; Hans Biesalski
Journal:  BMC Res Notes       Date:  2013-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.